Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines

Leukemia Research

Volumn 22, Issue 7, 1998, Pages 611-618

  Fujimura, Satoshi ^a   Suzumiya, Junji ^a   Anzai, Keizo ^a   Ohkubo, Kumiko ^a   Hata, Tomoko ^b   Yamada, Yasuaki ^b   Kamihira, Shimeru ^b   Kikuchi, Masahiro ^a   Ono, Junko ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; ATL cell line; CDK inhibitor; Cell cycle; Cell growth; Retinoic acid

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2 RECEPTOR; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; RETINOIC ACID;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA;

ADULT; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; HUMANS; ISOTRETINOIN; LEUKEMIA, T-CELL; RETINOIDS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031868246     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00049-6     Document Type: Article

References (42)

1. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 50:1977;481.
2. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 77:1980;7415.
3. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 78:1981;6476.
4. Shimoyama M, Members of the Lymphoma Study Group (1984-1987). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br J Haematol 1991;79:428.
5. Taguchi H., Kinoshita K., Takatsuki K., Tomonaga M., Araki K., Arima N., Ikeda S., Uozumi K., Kohno H., Kawano F., Kikuchi H., Takahashi H., Tamura K., Chiyoda S., Tsuda H., Nishimura H., Hosokawa T., Matsuzaki H., Momita S., Yamada O., Miyoshi I. An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquired Immune Deficiency Syndromes Human Retrovirol. 12:1996;182.
6. Tagaya Y., Maeda Y., Mitsui A., Kondo N., Matsui H., Hamuro J., Brown N., Arai K., Yokota T., Wakasugi H., Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement or dithiol-reduction in the IL-2 receptor induction. EMBO J. 8:1989;757.
7. Tagaya Y., Okada M., Sugie K., Kasahara T., Kondo N., Hamuro J., Matsushima K., Dinarello C.A., Yodoi J. IL-2 receptor (p55)/Tac-inducing factor: purification and characterization of adult T cell leukemia-derived factor. J Immunol. 140:1988;2614.
8. Masutani H, Nakamura H, Ueda Y, Kitaoka Y, Kawabe T, Iwata S, Mitsui A, Yodoi J. ADF (adult T cell leukemia-derived factor)/human thioredoxin and viral infection: possible new therapeutic approach, in: Friedman H, Klein TW, Yamaguchi H, editors. Microbial Infections: Role of Biological Response Modifiers. New York: Plenum Press, 1992:265.
9. U-Taniguchi Y., Furuke K., Masutani H., Nakamura H., Yodoi J. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of the thioredoxin reductase inhibitors. Oncol Res. 7:1995;183.
10. Maeda Y., Miyatake J., Sono H., Matsuda M., Tatsumi Y., Horiuchi F., Irimajiri K., Horiuchi A. 13-cis retinoic acid inhibits growth of adult T cell leukemia cells and causes apoptosis; possible new indication for retinoid therapy. Intern Med. 35:1996;180.
11. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA. 77:1980;2936.
12. Huang M.E., Ye Y.C., Chen S.R., Chai J.R., Lu J.X., Zhoa L., Gu L.J., Wang Z.Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:1988;567.
13. Levin A.A., Sturzenbecker L.J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., Grippo J.F. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα Nature. 355:1992;359.
14. Heyman R.A., Mangelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., Thaller C. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 68:1992;397.
15. Harwig S., Strauss M. The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem. 246:1997;581.
16. Beijersbergen R.L., Bernards R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta. 1287:1996;103.
17. 1 cyclin-dependent kinases. Genes Dev. 9:1995;1149.
18. Yamada Y., Nagata Y., Kamihira S., Tagawa M., Ichimaru M., Tomonaga M., Shiku H. IL-2-dependent ATL cell lines with phenotypes differing from the original leukemia cells. Leukemia Res. 15:1991;619.
19. + ATL cells: induction of CD4 expression. Br J Haematol. 88:1994;234.
20. Yamada Y., Ohmoto Y., Hata T., Yamamura M., Murata K., Tsukasaki K., Kohno T., Chen Y., Kamihira S., Tomonaga M. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leukemia Lymphoma. 21:1996;443.
21. Murayama A., Suzuki T., Matsui M. Biological effect of geometrical isomers of retinoic acid on human promyelocytic leukemia (HL-60) cells. Proc Jpn Acad. 70B:1994;81.
22. Murayama A., Suzuki T., Matsui M. Photoisomerization of retinoic acids in ethanol under room light: a warning for cell biological study of geometrical isomers of retinoids. J Nutritional Sci Vitaminol. 43:1997;167.
23. INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood. 87:1996;4949.
24. Hirama T., Koeffler H.P. Role of the cyclin-dependent kinese inhibitors in the development of cancer. Blood. 86:1995;841.
25. Waf1/Cip1/Sdi1. Oncogene. 12:1996;1645.
26. waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. Blood. 88:1996;1551.
27. Yamato K., Oka T., Hiroi M., Iwahara Y., Sugito S., Tsuchida N., Miyoshi I. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells. Jpn J Cancer Res. 84:1993;4.
28. Gartenhaus R.B., Wang P. Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes. Leukemia. 9:1995;2082.
29. Steinman R.A., Hoffman B., Iro A., Guillouf C., Liebermann D.A., El-Houseini M.E. Induction of p21(WAF-1/CIP1) during differentiation. Oncogene. 9:1994;3389.
30. Jiang H., Lin J., Su Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397.
31. WAF1/CIP1 expression by p53-independent pathways. Oncogene. 12:1996;1557.
32. WAF1/CIP1 gene by retinoic acid receptor. J Biol Chem. 271:1996;31723.
33. Gartenhaus R.B., Wang P., Hoffmann P. Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway. Proc Natl Acad Sci USA. 93:1996;265.
34. Dhein J., Walczak H., Bäumler C., Debatin K.-M., Krammer P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:1995;438.
35. Brunner T., Mogil R.J., LaFace D., Yoo N.J., Mahboubi A., Echeverri F., Martin S.J., Force W.R., Lynch D.H., Ware C.F., Green D.R. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates acivation-induced apoptosis in T-cell hybridomas. Nature. 373:1995;441.
36. Ju S.-T., Panka D.J., Cui H., Ettinger R., El-Khatib M., Sherr D.H., Stanger B.Z., Marshak-Rothstein A. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:1995;444.
37. Yang Y., Minucci S., Ozato K., Heyman R.A., Ashwell J.D. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J Biol Chem. 270:1995;18672.
38. Bissonnette R.P., Brunner T., Lazarchik S.B., Yoo N.J., Boehm M.F., Green D.R., Heyman R.A. 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol Cell Biol. 15:1995;5576.
39. Miyatake J., Maeda Y. Inhibition of proliferation and CD25 down-regulation by retionic acid in human adult T cell leukemia cells. Leukemia. 11:1997;401.
40. Tsukasaki K., Fujimoto T., Hata T., Yamada Y., Kamihira S., Tomonaga M. Concomitant complete remission of APL and smoldering ATL following ATRA therapy in a patient with the two diseases simultaneously. Leukemia. 9:1995;1797.
41. Kizaki M., Koeffler H.P., Lin C.-W., Miller C.W. Expression of retinoic acid receptor mRNA in hematopoietic cells. Leukemia Res. 14:1990;645.
42. Greene M.E., Blumberg B., McBride O.W., Yi H.F., Kronquist K., Kwan K., Hsieh L., Greene G., Nimer S.D. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expression. 4:1995;281.